Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
✍ Scribed by Tsao, Ming-Sound; Sakurada, Akira; Cutz, Jean-Claude; Zhu, Chang-Qi; Kamel-Reid, Suzanne; Squire, Jeremy; Lorimer, Ian; Zhang, Tong; Liu, Ni; Daneshmand, Manijeh; Marrano, Paula; da Cunha Santos, Gilda; Lagarde, Alain; Richardson, Frank; Seymour, Lesley; Whitehead, Marlo; Ding, Keyue; Pater, Joseph; Shepherd, Frances A.
- Book ID
- 118045301
- Publisher
- Massachusetts Medical Society
- Year
- 2005
- Tongue
- English
- Weight
- 522 KB
- Volume
- 353
- Category
- Article
- ISSN
- 0096-6762
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Clinical trials may offer patients innovative therapeutic options with potentially better outcomes, which are particularly relevant for patients afflicted with lung carcinoma, because current therapies provide only modest survival benefits. Only approximately 5% of patien